The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada

Abstract

Background We described the impact of different lengths of lookback window (LW), a retrospective time period to observe diagnoses in administrative data, on the prevalence and incidence of eight chronic diseases. Methods Our study populations included people living with HIV (N = 5151) and 1:5 age-sex-matched HIV-negative individuals (N = 25,755) in British Columbia, Canada, with complete follow-up between 1996 and 2012. We measured period prevalence and incidence of diseases in 2012 using LWs ranging from 1 to 16 years. Cases were deemed prevalent if identified in 2012 or within a defined LW, and incident if newly identified in 2012 with no previous cases detected within a defined LW. Chronic disease cases were ascertained using published case-finding algorithms applied to population-based provincial administrative health datasets. Results Overall, using cases identified by the full 16-year LW as the reference, LWs ≥8 years and ≥ 4 years reduced the proportion of misclassified prevalent and incidence cases of most diseases to < 20%, respectively. The impact of LWs varied across diseases and populations. Conclusions This study underscored the importance of carefully choosing LWs and demonstrated data-driven approaches that may inform these choices. To improve comparability of prevalence and incidence estimates across different settings, we recommend transparent reporting of the rationale and limitations of chosen LWs.

Disability-adjusted life years associated with chronic comorbidities among people living with and without HIV: Estimating health burden in British Columbia, Canada

“…To mitigate administrative data's susceptibility to coding errors, whenever possible, we utilized published BC Ministry of Health's case-finding algorithms to identify prevalent comorbidity diagnoses from hospitalizations and day-surgeries, physician visits, laboratory and diagnostic procedures, and prescription drug dispensation datasets, considering BC-specific claims-related practices. Moreover, with over 10 years of follow-up and a judicious 5-year lookback window [77], we are confident in our ability to capture most prevalent cases in both populations, upholding the validity of our YLD estimations. Second, the scarcity of information on disease severity distribution is a widely recognized problem [18,78,79].…”

An Analytical Approach for Temporal Infection Mapping and Composite Index Development

“…FDA can often extract additional information contained in functions and their derivatives that would not normally be available from the application of traditional statistical methods, which facilitates modeling and forecasting data across a range of health and population issues to better understand prevalence trends, risk factors, and effective measures [33]. Through FDA analysis, data with large sample size can be found and provide useful bases for post-observation [51], which represents a change in the concept of processing time series and related data [52].…”

Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada

“…Treatment retention was defined as any episode lasting ≥ 12 months. A five-year look-back window (LBW) was used to evaluate OAT dispensation and retention prior to the start of the study period ( Nanditha et al, 2022 ). Therapeutic dose – an optimal dosing level that effectively prevents craving and withdrawal symptoms – was set at ≥ 60 mg for methadone, ≥ 240 mg morphine equivalent (MME) for SROM, ≥ 12 mg for Buprenorphine/Naloxone, ≥ 200 mg for iOAT ( College, 2022 , British Columbia Centre on Substance Use and British Columbia Ministry of Health, 2017 , Centre, 2020 ).…”